تعديل

Affichage des articles dont le libellé est Shkreli's KaloBios buys Chagas disease drug rights. Afficher tous les articles
Affichage des articles dont le libellé est Shkreli's KaloBios buys Chagas disease drug rights. Afficher tous les articles

jeudi 3 décembre 2015

Shkreli's KaloBios buys Chagas disease drug rights, shares soar

(Reuters) - KaloBios Pharmaceuticals Inc, which recently appointed controversial head of Turing Pharmaceuticals Martin Shkreli as CEO, said it was acquiring worldwide rights to a compound being developed for the treatment of Chagas disease.











http://ift.tt/1XDCGbz

from Reuters: Health News
via animenewspro